1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Cancer of Stomach in 2 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hakomori, S | 1 |
Peng, J | 1 |
Liang, YY | 1 |
Fang, JC | 1 |
Shi, YJ | 1 |
Wang, DS | 1 |
2 other studies available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Cancer of Stomach
Article | Year |
---|---|
Novel endothelial cell activation factor(s) released from activated platelets which induce E-selectin expression and tumor cell adhesion to endothelial cells: a preliminary note.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Biological Factors; Cell Adhesion | 1994 |
[Study on the relationship between two second-messenger pathways on the regulation of proliferation and differentiation in MGc 80-3 cells].
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetamides; Antineoplastic Agents; Cell Differentiati | 1993 |